Skip to main content
OpenTrials

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

490 public trials 154 recruiting studies
Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Recruiting

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

NCT06622057

Conditions
Adenocarcinoma, Biliary Tract Cancer (BTC), Biliary Tract Diseases, +9 more
Locations
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • University Hospital Cleveland Medical Center Cleveland, Ohio, United States
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • The University of Arizona Cancer Center Tucson, Arizona, United States
View Trial Details
Recruiting

Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement

NCT05727176

Conditions
Adenocarcinoma, Advanced Cholangiocarcinoma, Carcinoma, +6 more
Locations
  • University of California San Diego UCSD - Moores Cancer Center La Jolla, California, United States
  • Tampa General Hospital Cancer Institute Tampa, Florida, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
View all 65 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

NCT07717437

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Monash Medical Centre Clayton, Victoria, Australia
View all 31 locations
View Trial Details

Related conditions